Defense at the border: the blood–brain barrier versus bacterial foreigners

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

References

• 1  Baraff LJ, Lee SI, Schriger DL. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr. Infect. Dis. J.12(5),389–394 (1993).
  Medline CASGoogle Scholar
• 2  Grimwood K, Anderson P, Anderson V, Tan L, Nolan T. Twelve year outcomes following bacterial meningitis: further evidence for persisting effects. Arch. Dis. Child.83(2),111–116 (2000).
  Medline CASGoogle Scholar
• 3  Eskola J, Peltola H, Takala AK et al. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy. N. Engl. J. Med.317(12),717–722 (1987).
  Medline CASGoogle Scholar
• 4  Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin. Microbiol. Rev.13(2),302–317 (2000).
  Medline CASGoogle Scholar
• 5  Watt JP, Wolfson LJ, O’Brien KL et al. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet374(9693),903–911 (2009).
  MedlineGoogle Scholar
• 6  O’Brien KL, Wolfson LJ, Watt JP et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet374(9693),893–902 (2009).
  MedlineGoogle Scholar
• 7  Thigpen MC, Whitney CG, Messonnier NE et al. Bacterial meningitis in the United States, 1998–2007. N. Engl. J. Med.364(21),2016–2025 (2011).
  Medline CASGoogle Scholar
• 8  Kaplan SL, Mason EO Jr, Wald ER et al. Decrease of invasive pneumococcal infections in children among 8 children’s hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics113(3 Pt 1),443–449 (2004).
  MedlineGoogle Scholar
• 9  Nakhla I, Frenck RW Jr, Teleb NA et al. The changing epidemiology of meningococcal meningitis after introduction of bivalent A/C polysaccharide vaccine into school-based vaccination programs in Egypt. Vaccine23(25),3288–3293 (2005).
  MedlineGoogle Scholar
• 10  Gray SJ, Trotter CL, Ramsay ME et al. Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit. J. Med. Microbiol.55(Pt 7),887–896 (2006).
  MedlineGoogle Scholar
• 11  Molyneux EM, Mankhambo LA, Phiri A et al. The outcome of non-typhoidal Salmonella meningitis in Malawian children, 1997–2006. Ann. Trop. Paediatr.29(1),13–22 (2009).
  Medline CASGoogle Scholar
• 12  Molyneux EM, Walsh AL, Malenga G, Rogerson S, Molyneux ME. Salmonella meningitis in children in Blantyre, Malawi, 1996–1999. Ann. Trop. Paediatr.20(1),41–44 (2000).
  Medline CASGoogle Scholar
• 13  Vaagland H, Blomberg B, Kruger C, Naman N, Jureen R, Langeland N. Nosocomial outbreak of neonatal Salmonella enterica serotype Enteritidis meningitis in a rural hospital in northern Tanzania. BMC Infect. Dis.4,35 (2004).
  MedlineGoogle Scholar
• 14  Iriso R, Ocakacon R, Acayo JA, Mawanda MA, Kisayke A. Bacterial meningitis following introduction of Hib conjugate vaccine in northern Uganda. Ann. Trop. Paediatr.28(3),211–216 (2008).
  Medline CASGoogle Scholar
• 15  Gordon MA, Graham SM, Walsh AL et al. Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica serovar Typhimurium infection associated with multidrug resistance among adults and children in Malawi. Clin. Infect. Dis.46(7),963–969 (2008).
  MedlineGoogle Scholar
• 16  Owusu-Ofori A, Scheld WM. Treatment of Salmonella meningitis: two case reports and a review of the literature. Int. J. Infect. Dis.7(1),53–60 (2003).
  MedlineGoogle Scholar
• 17  Brouwer MC, Tunkel AR, Van De Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin. Microbiol. Rev.23(3),467–492 (2010).
  Medline CASGoogle Scholar
• 18  Dawson KG, Emerson JC, Burns JL. Fifteen years of experience with bacterial meningitis. Pediatr. Infect. Dis. J.18(9),816–822 (1999).
  Medline CASGoogle Scholar
• 19  Nigrovic LE, Kuppermann N, Malley R. Children with bacterial meningitis presenting to the emergency department during the pneumococcal conjugate vaccine era. Acad. Emerg. Med.15(6),522–528 (2008).
  MedlineGoogle Scholar
• 20  Group TWYIS. Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study. Pediatr. Infect. Dis. J.18(10 Suppl.),S17–S22 (1999).
  MedlineGoogle Scholar
• 21  Zaidi AK, Thaver D, Ali SA, Khan TA. Pathogens associated with sepsis in newborns and young infants in developing countries. Pediatr. Infect. Dis. J.28(1 Suppl),S10–S18 (2009).
  MedlineGoogle Scholar
• 22  Phares CR, Lynfield R, Farley MM et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999–2005. JAMA299(17),2056–2065 (2008).
  Medline CASGoogle Scholar
• 23  Van Dyke MK, Phares CR, Lynfield R et al. Evaluation of universal antenatal screening for group B Streptococcus. N. Engl. J. Med.360(25),2626–2636 (2009).
  Medline CASGoogle Scholar
• 24  Stoll BJ, Hansen N, Fanaroff AA et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N. Engl. J. Med.347(4),240–247 (2002).
  MedlineGoogle Scholar
• 25  Stoll BJ, Hansen NI, Sanchez PJ et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics127(5),817–826 (2011).
  MedlineGoogle Scholar
• 26  Bekondi C, Bernede C, Passone N et al. Primary and opportunistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus. Int. J. Infect. Dis.10(5),387–395 (2006).
  MedlineGoogle Scholar
• 27  Swe KS, Nagel G, Van Der Westhuizen M, Hoosen AA. Salmonella Typhimurium meningitis in an adult patient with AIDS. J. Clin. Pathol.61(1),138–139 (2008).
  MedlineGoogle Scholar
• 28  Fernandez Guerrero ML, Ramos JM, Nunez A, De Gorgolas M. Focal infections due to non-typhi Salmonella in patients with AIDS: report of 10 cases and review. Clin. Infect. Dis.25(3),690–697 (1997).
  Medline CASGoogle Scholar
• 29  Lun ZR, Wang QP, Chen XG, Li AX, Zhu XQ. Streptococcus suis: an emerging zoonotic pathogen. Lancet Infect. Dis.7(3),201–209 (2007).
  MedlineGoogle Scholar
• 30  Gottschalk M, Xu J, Calzas C, Segura M. Streptococcus suis: a new emerging or an old neglected zoonotic pathogen? Future Microbiol.5(3),371–391 (2010).
  Google Scholar
• 31  Aguilar J, Urday-Cornejo V, Donabedian S, Perri M, Tibbetts R, Zervos M. Staphylococcus aureus meningitis: case series and literature review. Medicine89(2),117–125 (2010).
  MedlineGoogle Scholar
• 32  Pintado V, Meseguer MA, Fortun J et al. Clinical study of 44 cases of Staphylococcus aureus meningitis. Eur. J. Clin. Microbiol. Infect. Dis.21(12),864–868 (2002).
  Medline CASGoogle Scholar
• 33  Lerche A, Rasmussen N, Wandall JH, Bohr VA. Staphylococcus aureus meningitis: a review of 28 consecutive community-acquired cases. Scand. J. Infect. Dis.27(6),569–573 (1995).
  Medline CASGoogle Scholar
• 34  Brouwer MC, Keizerweerd GD, De Gans J, Spanjaard L, Van De Beek D. Community acquired Staphylococcus aureus meningitis in adults. Scand. J. Infect. Dis.41(5),375–377 (2009).
  MedlineGoogle Scholar
• 35  Jernigan JA, Stephens DS, Ashford DA et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg. Infect. Dis.7(6),933–944 (2001).
  Medline CASGoogle Scholar
• 36  Bales ME, Dannenberg AL, Brachman PS, Kaufmann AF, Klatsky PC, Ashford DA. Epidemiologic response to anthrax outbreaks: field investigations, 1950–2001. Emerg. Infect. Dis.8(10),1163–1174 (2002).
  MedlineGoogle Scholar
• 37  Ramsay CN, Stirling A, Smith J et al. An outbreak of infection with Bacillus anthracis in injecting drug users in Scotland. EuroSurveill.15(2), (2010).
  Google Scholar
• 38  Lanska DJ. Anthrax meningoencephalitis. Neurology59(3),327–334 (2002).
  MedlineGoogle Scholar
• 39  Stephens DS. Uncloaking the meningococcus: dynamics of carriage and disease. Lancet353(9157),941–942 (1999).
  Medline CASGoogle Scholar
• 40  Kim KS, Itabashi H, Gemski P, Sadoff J, Warren RL, Cross AS. The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat. J. Clin. Invest.90(3),897–905 (1992).
  Medline CASGoogle Scholar
• 41  Moxon ER, Ostrow PT. Haemophilus influenzae meningitis in infant rats: role of bacteremia in pathogenesis of age-dependent inflammatory responses in cerebrospinal fluid. J. Infect. Dis.135(2),303–307 (1977).
  Medline CASGoogle Scholar
• 42  La Scolea LJ Jr, Dryja D. Quantitation of bacteria in cerebrospinal fluid and blood of children with meningitis and its diagnostic significance. J. Clin. Microbiol.19(2),187–190 (1984).
  MedlineGoogle Scholar
• 43  Petersdorf RG, Swarner DR, Garcia M. Studies on the pathogenesis of meningitis. II. Development of meningitis during pneumococcal bacteremia. J. Clin. Invest.41,320–327 (1962).
  Medline CASGoogle Scholar
• 44  Ferrieri P, Burke B, Nelson J. Production of bacteremia and meningitis in infant rats with group B streptococcal serotypes. Infect. Immun.27(3),1023–1032 (1980).
  Medline CASGoogle Scholar
• 45  Bell LM, Alpert G, Campos JM, Plotkin SA. Routine quantitative blood cultures in children with Haemophilus influenzae or Streptococcus pneumoniae bacteremia. Pediatrics76(6),901–904 (1985).
  Medline CASGoogle Scholar
• 46  Nakamura S, Shchepetov M, Dalia AB et al. Molecular basis of increased serum resistance among pulmonary isolates of non-typeable Haemophilus influenzae. PLoS Pathog.7(1),E1001247 (2011).
  Medline CASGoogle Scholar
• 47  Mereghetti L, Sitkiewicz I, Green NM, Musser JM. Extensive adaptive changes occur in the transcriptome of Streptococcus agalactiae (group B Streptococcus) in response to incubation with human blood. PLoS One3(9),E3143 (2008).
  MedlineGoogle Scholar
• 48  Echenique-Rivera H, Muzzi A, Del Tordello E et al. Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survival. PLoS Pathog.7(5),E1002027 (2011).
  Medline CASGoogle Scholar
• 49  Santi I, Scarselli M, Mariani M et al. BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood. Mol. Microbiol.63(3),754–767 (2007).
  Medline CASGoogle Scholar
• 50  Sukumaran SK, Shimada H, Prasadarao NV. Entry and intracellular replication of Escherichia coli K1 in macrophages require expression of outer membrane protein A. Infect. Immun.71(10),5951–5961 (2003).
  Medline CASGoogle Scholar
• 51  Mittal R, Prasadarao NV. gp96 expression in neutrophils is critical for the onset of Escherichia coli K1 (RS218) meningitis. Nat. Commun.2,552 (2011).▪ Demonstrates mechanisms that promote bacterial bloodstream survival and subsequent blood–brain barrier (BBB) penetration.
  MedlineGoogle Scholar
• 52  Mittal R, Sukumaran SK, Selvaraj SK et al. Fcgamma receptor I alpha chain (CD64) expression in macrophages is critical for the onset of meningitis by Escherichia coli K1. PLoS Pathog.6(11),E1001203 (2010).
  MedlineGoogle Scholar
• 53  Mittal R, Krishnan S, Gonzalez-Gomez I, Prasadarao NV. Deciphering the roles of outer membrane protein A extracellular loops in the pathogenesis of Escherichia coli K1 meningitis. J. Biol. Chem.286(3),2183–2193 (2011).
  Medline CASGoogle Scholar
• 54  Pfister HW, Borasio GD, Dirnagl U, Bauer M, Einhaupl KM. Cerebrovascular complications of bacterial meningitis in adults. Neurology42(8),1497–1504 (1992).
  Medline CASGoogle Scholar
• 55  Koedel U, Frankenberg T, Kirschnek S et al. Apoptosis is essential for neutrophil functional shutdown and determines tissue damage in experimental pneumococcal meningitis. PLoS Pathog.5(5),E1000461 (2009).
  MedlineGoogle Scholar
• 56  Banerjee A, Kim BJ, Carmona EM et al. Bacterial Pili exploit integrin machinery to promote immune activation and efficient blood–brain barrier penetration. Nat. Commun.2,462 (2011).
  MedlineGoogle Scholar
• 57  Nguyen TH, Tran TH, Thwaites G et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N. Engl. J. Med.357(24),2431–2440 (2007).
  Medline CASGoogle Scholar
• 58  Peltola H, Roine I, Fernandez J et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. Clin. Infect. Dis.45(10),1277–1286 (2007).
  Medline CASGoogle Scholar
• 59  Van De Beek D, Farrar JJ, De Gans J et al. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol.9(3),254–263 (2010).
  Medline CASGoogle Scholar
• 60  Scarborough M, Gordon SB, Whitty CJ et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N. Engl. J. Med.357(24),2441–2450 (2007).
  Medline CASGoogle Scholar
• 61  Brouwer MC, Mcintyre P, De Gans J, Prasad K, Van De Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst. Rev. (9),CD004405 (2010).
  MedlineGoogle Scholar
• 62  Abbott NJ, Ronnback L, Hansson E. Astrocyte–endothelial interactions at the blood–brain barrier. Nat. Rev. Neurosci.7(1),41–53 (2006).
  Medline CASGoogle Scholar
• 63  Rubin LL, Staddon JM. The cell biology of the blood–brain barrier. Annu. Rev. Neurosci.22,11–28 (1999).
  Medline CASGoogle Scholar
• 64  Pulzova L, Bhide MR, Andrej K. Pathogen translocation across the blood–brain barrier. FEMS Immunol. Med. Microbiol.57(3),203–213 (2009).
  Medline CASGoogle Scholar
• 65  Dejana E, Corada M, Lampugnani MG. Endothelial cell-to-cell junctions. FASEB9(10),910–918 (1995).
  Medline CASGoogle Scholar
• 66  Hawkins RA, O’Kane RL, Simpson IA, Vina JR. Structure of the blood–brain barrier and its role in the transport of amino acids. J. Nutr.136(1 Suppl.),218S–226S (2006).
  Medline CASGoogle Scholar
• 67  Schulze C, Firth JA. Immunohistochemical localization of adherens junction components in blood–brain barrier microvessels of the rat. Cell Sci.104(Pt 3),773–782 (1993).
  MedlineGoogle Scholar
• 68  Wolburg H, Lippoldt A. Tight junctions of the blood–brain barrier: development, composition and regulation. Vascul. Pharmacol.38(6),323–337 (2002).
  Medline CASGoogle Scholar
• 69  Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell84(3),345–357 (1996).
  Medline CASGoogle Scholar
• 70  Furuse M, Itoh M, Hirase T, Nagafuchi A, Yonemura S, Tsukita S. Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J. Cell. Biol.127(6 Pt 1),1617–1626 (1994).
  Medline CASGoogle Scholar
• 71  Martin-Padura I, Lostaglio S, Schneemann M et al. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J. Cell. Biol.142(1),117–127 (1998).
  Medline CASGoogle Scholar
• 72  Braga VM. Cell-cell adhesion and signalling. Curr. Opin. Cell Biol.14(5),546–556 (2002).
  Medline CASGoogle Scholar
• 73  Matter K, Balda MS. Signalling to and from tight junctions. Nat. Rev. Mol. Cell Biol.4(3),225–236 (2003).
  Medline CASGoogle Scholar
• 74  Wheelock MJ, Johnson KR. Cadherin-mediated cellular signaling. Curr. Opin. Cell Biol.15(5),509–514 (2003).
  Medline CASGoogle Scholar
• 75  Taddei A, Giampietro C, Conti A et al. Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat. Cell Biol.10(8),923–934 (2008).
  Medline CASGoogle Scholar
• 76  Stins MF, Prasadarao NV, Ibric L, Wass CA, Luckett P, Kim KS. Binding characteristics of S fimbriated Escherichia coli to isolated brain microvascular endothelial cells. Am. J. Pathol.145(5),1228–1236 (1994).▪ Pioneering study describing the development of the human brain microvascular cell line.
  Medline CASGoogle Scholar
• 77  Weksler BB, Subileau EA, Perriere N et al. Blood–brain barrier-specific properties of a human adult brain endothelial cell line. FASEB19(13),1872–1874 (2005).
  Medline CASGoogle Scholar
• 78  Greiffenberg L, Goebel W, Kim KS et al. Interaction of Listeria monocytogenes with human brain microvascular endothelial cells: InlB-dependent invasion, long-term intracellular growth, and spread from macrophages to endothelial cells. Infect. Immun.66(11),5260–5267 (1998).
  Medline CASGoogle Scholar
• 79  Wickham ME, Brown NF, Provias J, Finlay BB, Coombes BK. Oral infection of mice with Salmonella enterica serovar Typhimurium causes meningitis and infection of the brain. BMC Infect. Dis.7,65 (2007).
  MedlineGoogle Scholar
• 80  Doran KS, Liu GY, Nizet V. Group B streptococcal beta-hemolysin/cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis. J. Clin. Invest.112(5),736–744. (2003).
  Medline CASGoogle Scholar
• 81  Smith AL, Smith DH, Averill DR Jr, Marino J, Moxon ER. Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation. Infect. Immun.8(2),278–290 (1973).
  Medline CASGoogle Scholar
• 82  Uchiyama S, Carlin AF, Khosravi A et al. The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion. J. Exp. Med.206(9),1845–1852 (2009).
  Medline CASGoogle Scholar
• 83  Sheen TR, Ebrahimi CM, Hiemstra IH, Barlow SB, Peschel A, Doran KS. Penetration of the blood–brain barrier by Staphylococcus aureus: contribution of membrane-anchored lipoteichoic acid. J. Mol. Med.88(6),633–639 (2010).
  Medline CASGoogle Scholar
• 84  Nizet V, Kim KS, Stins M et al. Invasion of brain microvascular endothelial cells by group B streptococci. Infect. Immun.65(12),5074–5081 (1997).
  Medline CASGoogle Scholar
• 85  Stins MF, Badger J, Sik Kim K. Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells. Microb. Pathog.30(1),19–28 (2001).
  Medline CASGoogle Scholar
• 86  Ring A, Weiser JN, Tuomanen EI. Pneumococcal trafficking across the blood–brain barrier. Molecular analysis of a novel bidirectional pathway. J. Clin. Invest.102(2),347–360 (1998).
  Medline CASGoogle Scholar
• 87  Jain SK, Paul-Satyaseela M, Lamichhane G, Kim KS, Bishai WR. Mycobacterium tuberculosis invasion and traversal across an in vitro human blood–brain barrier as a pathogenic mechanism for central nervous system tuberculosis. J. Infect. Dis.193(9),1287–1295 (2006).
  Medline CASGoogle Scholar
• 88  Nikulin J, Panzner U, Frosch M, Schubert-Unkmeir A. Intracellular survival and replication of Neisseria meningitidis in human brain microvascular endothelial cells. Int. J. Med. Microbiol.296(8),553–558 (2006).
  Medline CASGoogle Scholar
• 89  Van Sorge NM, Zialcita PA, Browne SH, Quach D, Guiney DG, Doran KS. Penetration and activation of brain endothelium by Salmonella enterica serovar Typhimurium. J. Infect. Dis.203(3),401–405 (2011).
  MedlineGoogle Scholar
• 90  Prasadarao NV, Wass CA, Stins MF, Shimada H, Kim KS. Outer membrane protein A-promoted actin condensation of brain microvascular endothelial cells is required for Escherichia coli invasion. Infect. Immun.67(11),5775–5783 (1999).
  Medline CASGoogle Scholar
• 91  Das A, Asatryan L, Reddy MA et al. Differential role of cytosolic phospholipase A2 in the invasion of brain microvascular endothelial cells by Escherichia coli and Listeria monocytogenes. J. Infect. Dis.184(6),732–737 (2001).
  Medline CASGoogle Scholar
• 92  Kim KS. Mechanisms of microbial traversal of the blood–brain barrier. Nat. Rev. Microbiol.6(8),625–634 (2008).▪▪ Excellent review of bacterial and host factors involved in BBB penetration and pathogenesis of meningitis.
  Medline CASGoogle Scholar
• 93  Kim KS. Acute bacterial meningitis in infants and children. Lancet Infect. Dis.10(1),32–42 (2010).▪▪ Excellent review on the pathogenesis of bacterial meningitis.
  Medline CASGoogle Scholar
• 94  Badger JL, Wass CA, Weissman SJ, Kim KS. Application of signature-tagged mutagenesis for identification of Escherichia coli K1 genes that contribute to invasion of human brain microvascular endothelial cells. Infect. Immun.68(9),5056–5061 (2000).
  Medline CASGoogle Scholar
• 95  Doran KS, Engelson EJ, Khosravi A et al. Blood–brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J. Clin. Invest.115(9),2499–2507. (2005).
  Medline CASGoogle Scholar
• 96  Dietrich G, Kurz S, Hubner C et al. Transcriptome analysis of Neisseria meningitidis during infection. J. Bacteriol.185(1),155–164 (2003).
  Medline CASGoogle Scholar
• 97  Teng CH, Cai M, Shin S et al.Escherichia coli K1 RS218 interacts with human brain microvascular endothelial cells via type 1 fimbria bacteria in the fimbriated state. Infect. Immun.73(5),2923–2931 (2005).
  Medline CASGoogle Scholar
• 98  Badger JL, Wass CA, Kim KS. Identification of Escherichia coli K1 genes contributing to human brain microvascular endothelial cell invasion by differential fluorescence induction. Mol. Microbiol.36(1),174–182 (2000).
  Medline CASGoogle Scholar
• 99  Tazi A, Disson O, Bellais S et al. The surface protein HvgA mediates group B Streptococcus hypervirulence and meningeal tropism in neonates. J. Exp. Med.207(11),2313–2322 (2010).
  Medline CASGoogle Scholar
• 100  Mairey E, Genovesio A, Donnadieu E et al. Cerebral microcirculation shear stress levels determine Neisseria meningitidis attachment sites along the blood–brain barrier. J. Exp. Med.203(8),1939–1950 (2006).
  Medline CASGoogle Scholar
• 101  Maisey HC, Hensler M, Nizet V, Doran KS. Group B streptococcal pilus proteins contribute to adherence to and invasion of brain microvascular endothelial cells. J. Bacteriol.189(4),1464–1467 (2007).
  Medline CASGoogle Scholar
• 102  Van Sorge NM, Quach D, Gurney MA, Sullam PM, Nizet V, Doran KS. The group B streptococcal serine-rich repeat 1 glycoprotein mediates penetration of the blood–brain barrier. J. Infect. Dis.199(10),1479–1487 (2009).
  Medline CASGoogle Scholar
• 103  Kirchner M, Meyer TF. The PilC adhesin of the Neisseria type IV pilus-binding specificities and new insights into the nature of the host cell receptor. Mol. Microbiol.56(4),945–957 (2005).
  Medline CASGoogle Scholar
• 104  Telford JL, Barocchi MA, Margarit I, Rappuoli R, Grandi G. Pili in Gram-positive pathogens. Nat. Rev. Microbiol.4(7),509–519 (2006).
  Medline CASGoogle Scholar
• 105  Barocchi MA, Ries J, Zogaj X et al. A pneumococcal pilus influences virulence and host inflammatory responses. Proc. Natl Acad. Sci. USA103(8),2857–2862 (2006).
  Medline CASGoogle Scholar
• 106  Bagnoli F, Moschioni M, Donati C et al. A second pilus type in Streptococcus pneumoniae is prevalent in emerging serotypes and mediates adhesion to host cells. J. Bacteriol.190(15),5480–5492 (2008).
  Medline CASGoogle Scholar
• 107  St Geme JW 3rd, Cutter D. Influence of pili, fibrils, and capsule on in vitro adherence by Haemophilus influenzae type b. Mol. Microbiol.21(1),21–31 (1996).
  MedlineGoogle Scholar
• 108  St. Geme JW 3rd, Cutter D. Evidence that surface fibrils expressed by Haemophilus influenzae type b promote attachment to human epithelial cells. Mol. Microbiol.15(1),77–85 (1995).
  MedlineGoogle Scholar
• 109  Unkmeir A, Latsch K, Dietrich G et al. Fibronectin mediates Opc-dependent internalization of Neisseria meningitidis in human brain microvascular endothelial cells. Mol. Microbiol.46(4),933–946 (2002).
  Medline CASGoogle Scholar
• 110  Kim KJ, Elliott SJ, Di Cello F, Stins MF, Kim KS. The K1 capsule modulates trafficking of E. coli-containing vacuoles and enhances intracellular bacterial survival in human brain microvascular endothelial cells. Cell. Microbiol.5(4),245–252 (2003).
  Medline CASGoogle Scholar
• 111  St Geme JW 3rd, Falkow S. Loss of capsule expression by Haemophilus influenzae type b results in enhanced adherence to and invasion of human cells. Infect. Immun.59(4),1325–1333 (1991).
  MedlineGoogle Scholar
• 112  Hammerschmidt S, Muller A, Sillmann H et al. Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease. Mol. Microbiol.20(6),1211–1220 (1996).
  Medline CASGoogle Scholar
• 113  Khan NA, Wang Y, Kim KJ, Chung JW, Wass CA, Kim KS. Cytotoxic necrotizing factor-1 contributes to Escherichia coli K1 invasion of the central nervous system. J. Biol. Chem.277(18),15607–15612 (2002).
  Medline CASGoogle Scholar
• 114  Zysk G, Schneider-Wald BK, Hwang JH et al. Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae. Infect. Immun.69(2),845–852 (2001).
  Medline CASGoogle Scholar
• 115  Patrick D, Betts J, Frey EA, Prameya R, Dorovini-Zis K, Finlay BB. Haemophilus influenzae lipopolysaccharide disrupts confluent monolayers of bovine brain endothelial cells via a serum-dependent cytotoxic pathway. J. Infect. Dis.165(5),865–872 (1992).
  Medline CASGoogle Scholar
• 116  Wellmer A, Zysk G, Gerber J et al. Decreased virulence of a pneumolysin-deficient strain of Streptococcus pneumoniae in murine meningitis. Infect. Immun.70(11),6504–6508 (2002).
  Medline CASGoogle Scholar
• 117  Orihuela CJ, Mahdavi J, Thornton J et al. Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models. J. Clin. Invest.119(6),1638–1646 (2009).▪ Demonstrates a host receptor that acts as a common portal of bacterial entry.
  Medline CASGoogle Scholar
• 118  Swords WE, Ketterer MR, Shao J, Campbell CA, Weiser JN, Apicella MA. Binding of the non-typeable Haemophilus influenzae lipooligosaccharide to the PAF receptor initiates host cell signalling. Cell. Microbiol.3(8),525–536 (2001).
  Medline CASGoogle Scholar
• 119  Virji M, Saunders JR, Sims G, Makepeace K, Maskell D, Ferguson DJ. Pilus-facilitated adherence of Neisseria meningitidis to human epithelial and endothelial cells: modulation of adherence phenotype occurs concurrently with changes in primary amino acid sequence and the glycosylation status of pilin. Mol. Microbiol.10(5),1013–1028 (1993).
  Medline CASGoogle Scholar
• 120  Kim KJ, Chung JW, Kim KS. 67-kDa laminin receptor promotes internalization of cytotoxic necrotizing factor 1-expressing Escherichia coli K1 into human brain microvascular endothelial cells. J. Biol. Chem.280(2),1360–1368 (2005).
  Medline CASGoogle Scholar
• 121  Chung JW, Hong SJ, Kim KJ et al. 37-kDa laminin receptor precursor modulates cytotoxic necrotizing factor 1-mediated RhoA activation and bacterial uptake. J. Biol. Chem.278(19),16857–16862 (2003).
  Medline CASGoogle Scholar
• 122  Radin JN, Orihuela CJ, Murti G, Guglielmo C, Murray PJ, Tuomanen EI. Beta-Arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae. Infect. Immun.73(12),7827–7835 (2005).
  Medline CASGoogle Scholar
• 123  Rijneveld AW, Weijer S, Florquin S et al. Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice. J. Infect. Dis.189(4),711–716 (2004).
  MedlineGoogle Scholar
• 124  Kolberg J, Hoiby EA, Jantzen E. Detection of the phosphorylcholine epitope in Streptococci, Haemophilus and pathogenic Neisseriae by immunoblotting. Microb. Pathog.22(6),321–329 (1997).
  Medline CASGoogle Scholar
• 125  Weiser JN, Pan N, McGowan KL, Musher D, Martin A, Richards J. Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J. Exp. Med.187(4),631–640 (1998).
  Medline CASGoogle Scholar
• 126  Swords WE, Buscher BA, Ver Steeg Ii K et al. Non-typeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor. Mol. Microbiol.37(1),13–27 (2000).
  Medline CASGoogle Scholar
• 127  Kim SH, Turnbull J, Guimond S. Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J. Endocrinol.209(2),139–151 (2011).
  Medline CASGoogle Scholar
• 128  Chang YC, Wang Z, Flax LA et al. Glycosaminoglycan binding facilitates entry of a bacterial pathogen into central nervous systems. PLoS Pathog.7(6),e1002082 (2011).
  Medline CASGoogle Scholar
• 129  Fida NM, Al-Mughales J, Farouq M. Interleukin-1alpha, interleukin-6 and tumor necrosis factor-alpha levels in children with sepsis and meningitis. Pediatr. Int.48(2),118–124 (2006).
  Medline CASGoogle Scholar
• 130  Tang RB, Lee BH, Chung RL, Chen SJ, Wong TT. Interleukin-1beta and tumor necrosis factor-alpha in cerebrospinal fluid of children with bacterial meningitis. Childs Nerv. Syst.17(8),453–456 (2001).
  Medline CASGoogle Scholar
• 131  Lehmann AK, Halstensen A, Sornes S, Rokke O, Waage A. High levels of interleukin 10 in serum are associated with fatality in meningococcal disease. Infect. Immun.63(6),2109–2112 (1995).
  Medline CASGoogle Scholar
• 132  Leist TP, Frei K, Kam-Hansen S, Zinkernagel RM, Fontana A. Tumor necrosis factor alpha in cerebrospinal fluid during bacterial, but not viral, meningitis. Evaluation in murine model infections and in patients. J. Exp. Med.167(5),1743–1748 (1988).
  Medline CASGoogle Scholar
• 133  Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J. Exp. Med.169(1),333–338 (1989).
  Medline CASGoogle Scholar
• 134  Nagesh Babu G, Kumar A, Kalita J, Misra UK. Proinflammatory cytokine levels in the serum and cerebrospinal fluid of tuberculous meningitis patients. Neurosci. Lett.436(1),48–51 (2008).
  Medline CASGoogle Scholar
• 135  Cundell DR, Gerard NP, Gerard C, Idanpaan-Heikkila I, Tuomanen EI. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature377(6548),435–438 (1995).
  Medline CASGoogle Scholar
• 136  Banerjee A, Van Sorge NM, Sheen TR, Uchiyama S, Mitchell TJ, Doran KS. Activation of brain endothelium by pneumococcal neuraminidase NanA promotes bacterial internalization. Cell. Microbiol.12(11),1576–1588 (2010).
  Medline CASGoogle Scholar
• 137  Zhang WG, Khan AN, Kim KJ, Stins M, Kim KS. Transforming growth factor-beta increases Escherichia coli K1 adherence, invasion, and transcytosis in human brain microvascular endothelial cells. Cell. Tissue Res.309(2),281–286 (2002).
  Medline CASGoogle Scholar
• 138  Lembo A, Gurney MA, Burnside K et al. Regulation of CovR expression in group B Streptococcus impacts blood–brain barrier penetration. Mol. Microbiol.77(2),431–443 (2010).
  Medline CASGoogle Scholar
• 139  Sharief MK, Ciardi M, Thompson EJ. Blood–brain barrier damage in patients with bacterial meningitis: association with tumor necrosis factor-alpha but not interleukin-1 beta. J. Infect. Dis.166(2),350–358 (1992).
  Medline CASGoogle Scholar
• 140  Barichello T, Pereira JS, Savi GD et al. A kinetic study of the cytokine/chemokines levels and disruption of blood–brain barrier in infant rats after pneumococcal meningitis. J. Neuroimmunol.233(1–2),12–17 (2011).
  Medline CASGoogle Scholar
• 141  Kim KS, Wass CA, Cross AS. Blood–brain barrier permeability during the development of experimental bacterial meningitis in the rat. Exp. Neurol.145(1),253–257 (1997).
  Medline CASGoogle Scholar
• 142  Mittal R, Prasadarao NV. Nitric oxide/cGMP signalling induces Escherichia coli K1 receptor expression and modulates the permeability in human brain endothelial cell monolayers during invasion. Cell Microbiol.12(1),67–83 (2010).
  Medline CASGoogle Scholar
• 143  Winkler F, Koedel U, Kastenbauer S, Pfister HW. Differential expression of nitric oxide synthases in bacterial meningitis: role of the inducible isoform for blood–brain barrier breakdown. J. Infect. Dis.183(12),1749–1759 (2001).
  Medline CASGoogle Scholar
• 144  Leib SL, Kim YS, Black SM, Tureen JH, Tauber MG. Inducible nitric oxide synthase and the effect of aminoguanidine in experimental neonatal meningitis. J. Infect. Dis.177(3),692–700 (1998).
  Medline CASGoogle Scholar
• 145  Koedel U, Bernatowicz A, Paul R, Frei K, Fontana A, Pfister HW. Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide. Ann. Neurol.37(3),313–323 (1995).
  Medline CASGoogle Scholar
• 146  Mittal R, Gonzalez-Gomez I, Goth KA, Prasadarao NV. Inhibition of inducible nitric oxide controls pathogen load and brain damage by enhancing phagocytosis of Escherichia coli K1 in neonatal meningitis. Am. J. Pathol.176(3),1292–1305 (2010).
  Medline CASGoogle Scholar
• 147  Coureuil M, Lecuyer H, Scott MG et al. Meningococcus Hijacks a beta2-adrenoceptor/beta-Arrestin pathway to cross brain microvasculature endothelium. Cell143(7),1149–1160 (2010).
  Medline CASGoogle Scholar
• 148  Coureuil M, Mikaty G, Miller F et al. Meningococcal type IV pili recruit the polarity complex to cross the brain endothelium. Science325(5936),83–87 (2009).▪ Demonstrates paracellular transit at the BBB.
  Medline CASGoogle Scholar
• 149  Schubert-Unkmeir A, Konrad C, Slanina H, Czapek F, Hebling S, Frosch M. Neisseria meningitidis induces brain microvascular endothelial cell detachment from the matrix and cleavage of occludin: a role for MMP-8. PLoS Pathog.6(4),e1000874 (2010).
  MedlineGoogle Scholar
• 150  Sukumaran SK, Prasadarao NV. Escherichia coli K1 invasion increases human brain microvascular endothelial cell monolayer permeability by disassembling vascular-endothelial cadherins at tight junctions. J. Infect. Dis.188(9),1295–1309 (2003).
  Medline CASGoogle Scholar
• 151  Ebrahimi CM, Kern JW, Sheen TR et al. Penetration of the blood–brain barrier by Bacillus anthracis requires the pXO1-encoded BslA protein. J. Bacteriol.191(23),7165–7173 (2009).
  Medline CASGoogle Scholar
• 152  Ebrahimi CM, Sheen TR, Renken CW, Gottlieb RA, Doran KS. Contribution of lethal toxin and edema toxin to the pathogenesis of anthrax meningitis. Infect. Immun.79(7),2510–2518 (2011).
  Medline CASGoogle Scholar
• 153  Mukherjee DV, Tonry JH, Kim KS et al.Bacillus anthracis protease InhA increases blood–brain barrier permeability and contributes to cerebral hemorrhages. PLoS One6(3),E17921 (2011).
  Medline CASGoogle Scholar
• 154  Guichard A, McGillivray SM, Cruz-Moreno B, Van Sorge NM, Nizet V, Bier E. Anthrax toxins cooperatively inhibit endocytic recycling by the Rab11/Sec15 exocyst. Nature467(7317),854–858 (2010).
  Medline CASGoogle Scholar
• 155  Saez-Llorens X, Jafari HS, Severien C et al. Enhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anti-CD18 monoclonal antibodies and dexamethasone in experimental Haemophilus meningitis. J. Clin. Invest.88(6),2003–2011 (1991).
  Medline CASGoogle Scholar
• 156  Tuomanen EI, Saukkonen K, Sande S, Cioffe C, Wright SD. Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J. Exp. Med.170(3),959–969 (1989).
  Medline CASGoogle Scholar
• 157  Galanakis E, Di Cello F, Paul-Satyaseela M, Kim KS. Escherichia coli K1 induces IL-8 expression in human brain microvascular endothelial cells. Eur. Cytokine Netw.17(4),260–265 (2006).
  Medline CASGoogle Scholar
• 158  Vadeboncoeur N, Segura M, Al-Numani D, Vanier G, Gottschalk M. Pro-inflammatory cytokine and chemokine release by human brain microvascular endothelial cells stimulated by Streptococcus suis serotype 2. FEMS Immunol. Med. Microbiol.35(1),49–58 (2003).
  Medline CASGoogle Scholar
• 159  Wilson SL, Drevets DA. Listeria monocytogenes infection and activation of human brain microvascular endothelial cells. J. Infect. Dis.178(6),1658–1666 (1998).
  Medline CASGoogle Scholar
• 160  Sokolova O, Heppel N, Jagerhuber R et al. Interaction of Neisseria meningitidis with human brain microvascular endothelial cells: role of MAP- and tyrosine kinases in invasion and inflammatory cytokine release. Cell. Microbiol.6(12),1153–1166. (2004).
  Medline CASGoogle Scholar
• 161  Schubert-Unkmeir A, Sokolova O, Panzner U, Eigenthaler M, Frosch M. Gene expression pattern in human brain endothelial cells in response to Neisseria meningitidis. Infect. Immun.75(2),899–914. (2007).
  Medline CASGoogle Scholar
• 162  Krishnan V, Gaspar AH, Ye N, Mandlik A, Ton-That H, Narayana SV. An IgG-like domain in the minor pilin GBS52 of Streptococcus agalactiae mediates lung epithelial cell adhesion. Structure15(8),893–903 (2007).
  Medline CASGoogle Scholar
• 163  Van Sorge NM, Ebrahimi CM, McGillivray SM et al. Anthrax toxins inhibit neutrophil signaling pathways in brain endothelium and contribute to the pathogenesis of meningitis. PLoS One3(8),e2964 (2008).
  MedlineGoogle Scholar
• 164  Reddy MA, Wass CA, Kim KS, Schlaepfer DD, Prasadarao NV. Involvement of focal adhesion kinase in Escherichia coli invasion of human brain microvascular endothelial cells. Infect. Immun.68(11),6423–6430 (2000).
  Medline CASGoogle Scholar
• 165  Sukumaran SK, Prasadarao NV. Regulation of protein kinase C in Escherichia coli K1 invasion of human brain microvascular endothelial cells. J. Biol. Chem.277(14),12253–12262 (2002).
  Medline CASGoogle Scholar
• 166  Tenenbaum T, Bloier C, Adam R, Reinscheid DJ, Schroten H. Adherence to and invasion of human brain microvascular endothelial cells are promoted by fibrinogen-binding protein FbsA of Streptococcus agalactiae. Infect. Immun.73(7),4404–4409 (2005).
  Medline CASGoogle Scholar
• 167  Tenenbaum T, Spellerberg B, Adam R, Vogel M, Kim KS, Schroten H. Streptococcus agalactiae invasion of human brain microvascular endothelial cells is promoted by the laminin-binding protein Lmb. Microbes Infect.9(6),714–720 (2007).
  Medline CASGoogle Scholar
• 201  WHO Health Report 2004. www.who.int/whr/2004/en/report04_en.pdf
  Google Scholar
• 202  HiB Initiative. www.hibaction.org
  Google Scholar